Company Overview and News


Add OPGNW
to your dashboard

Headline News

OpGen's (OPGN) CEO Evan Jones on Q3 2017 Results - Earnings Call Transcript

2017-11-11 seekingalpha
Welcome to the OpGen Third Quarter 2017 Conference Call. At this time all participants are in a listen-only mode. Following management’s prepared remarks, we’ll hold a Q&A session. [Operator Instructions] As a reminder, this conference is being recorded, November 7, 2017. (46-3)

Medical Research Stock Performance Review -- OpGen, TearLab, TrovaGene, and PRA Health Sciences

2017-09-29 prnewswire
If you want a Stock Review on OPGN, TEAR, TROV, or PRAH then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. DailyStockTracker.com has issued research reports on OpGen Inc. (NASDAQ: OPGN), TearLab Corp. (NASDAQ: TEAR), TrovaGene Inc. (NASDAQ: TROV), and PRA Health Sciences Inc. (NASDAQ: PRAH). Medical Laboratories and Research companies focus on performing various tests on patients that give them information on patients' health. (124-0)

Here's What The OpGen Inc (NASDAQ:OPGN) Merck & Co., Inc. (NYSE:MRK) Agreement Really Means, And Why It's So Important - Market Exclusive

2017-07-20 marketexclusive
OpGen just signed a development deal with Merck to speed up infectious disease diagnosis by orders of magnitude. Here's how, and why it's so important to the antibiotics sector.

(OPGN), Thermo Fisher Scientific Inc (NYSE:TMO) - Here's What The Latest Thermo Fisher Approval Really Means And Why It's So Important | Benzinga

2017-07-20 benzinga
Thermo Fisher Scientific Inc. (NYSE: TMO) just announced that the Food and Drug Administration (FDA) has approved its Oncomine Dx Target Test, a next-generation sequencing test that simultaneously screens tumor samples for biomarkers associated with various available lung cancer therapies. (0-1)

BRIEF-Opgen ‍prices public offering to issue and sell 18.2 mln units

2017-07-14 reuters
* Opgen Inc - ‍priced a public offering to issue and sell 18.2 million units at an offering price per unit of $0.40​ Source: (bit.ly/2tUCOHV) Further company coverage:

Retailers Bon-Ton, Ross Stores Drop into Thursday’s 52-Week Low Club

2017-07-13 247wallst
July 13, 2017: Here are four stocks trading with heavy volume among 60 equities making new 52-week lows in Thursday’s session. On the NYSE, advancers led decliners by less than 8 to 7 and on the Nasdaq, decliners led advancers by about the same ratio.

Abercrombie & Fitch, Rite Aid Walk into Wednesday’s 52-Week Low Club

2017-07-12 247wallst
July 12, 2017: Here are four stocks trading with heavy volume among 73 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by nearly 4 to 1 and on the Nasdaq, advancers led decliners by about 3 to 1.

OpGen Form EX-99.1

2016-01-13 sec.gov
  Exhibit 99.1                                                                                                                      

OpGen Form 8-K (Current Report/Significant Event)

2016-01-13 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________   FORM 8-K _________________   CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): January 12, 2016 _________________   OpGen, Inc. (Exact name of registrant as specified in its charter) _________________   Delaware (State or other jurisdiction of incorporation or organization)   001-37367 (Commission File Number)  

OpGen Form 4 (Change in Ownership/Insider Trade)

2015-12-15 sec.gov
X0306 4 2015-12-10 0 0001293818 OPGEN INC OPGN,OPGNW 0001020741 JONES EVAN/ FA C/O OPGEN, INC. 708 QUINCE ORCHARD ROAD, SUITE 205 GAITHERSBURG MD 20878 1 1 1 0 Chief Executive Officer Common Stock 2015-12-10 4 P 0 50 1.65 A 2930082 I See footnote Common Stock 2015-12-10 4 P 0 100 1.83 A 2930182 I See footnote Common Stock 2015-12-11 4 P 0 1105 1.7827 A 2931287 I See footnote Common Stock 131156 I By spouse The securities are directly held by jVen Capital, LLC ("jVen Capital").

OpGen Form 4 (Change in Ownership/Insider Trade)

2015-12-12 sec.gov
X0306 4 2015-12-04 0 0001293818 OPGEN INC OPGN,OPGNW 0001020741 JONES EVAN/ FA C/O OPGEN, INC. 708 QUINCE ORCHARD ROAD, SUITE 205 GAITHERSBURG MD 20878 1 1 1 0 Chief Executive Officer Common Stock 2015-12-04 4 P 0 300 1.7566 A 2929432 I See footnote Common Stock 2015-12-07 4 P 0 600 1.7883 A 2930032 I See footnote Common Stock 131156 I By spouse The price reported in Column 4 is a weighted average price.

District of Columbia Hospital Association Chooses OpGen to Create Citywide Effort to Track Multidrug-Resistant Bacteria

2015-11-18 finance.yahoo
GAITHERSBURG, Md. and WASHINGTON, Nov. 18, 2015-- OpGen, Inc. and the District of Columbia Hospital Association today announced that Washington DC’ s public health departments will oversee a comprehensive ...

OpGen Form 8-K (Current Report/Significant Event)

2015-11-13 sec.gov
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________   FORM 8-K _________________   CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): November 12, 2015 _________________   OpGen, Inc. (Exact name of registrant as specified in its charter) _________________   Delaware (State or other jurisdiction of incorporation or organization) 001-37367 (Commission File Number) 06-16

OpGen Form EX-99.1

2015-11-13 sec.gov
Exhibit 99.1       OpGen Reports Third Quarter Financial Results and Provides Business Update   Conference call begins at 4:30 p.m. Eastern time today   GAITHERSBURG, Md. (November 12, 2015) – OpGen, Inc. (NASDAQ: OPGN), an early commercial-stage company using molecular testing and bioinformatics to help guide antibiotic therapy and to assist healthcare providers combat multi-drug resistant infections, today reported financial results for the three and nine months ended September 30, 2015.

OpGen Form EX-101.INS

2015-11-13 sec.gov
0001293818 2014-01-01 2014-09-30 0001293818 2015-01-01 2015-09-30 0001293818 2015-03-31 0001293818 2014-04-01 2014-06-30 0001293818 2015-05-01 2015-05-31 0001293818 2015-05-02 2015-05-08 0001293818 2014-07-01 2014-09-30 0001293818 2015-07-01 2015-09-30 0001293818 2015-07-14 0001293818 2013-09-01 2013-09-30 0001293818 2015-09-30 0001293818 2015-10-30 0001293818 2014-12-31 0001293818 2014-09-30 0001293818 2013-12-31 0001293818 us-gaap:RedeemableConvertiblePreferredStockMember 2015-09-30 0001293818